Assertio Therapeutics, Inc. (ASRT): Price and Financial Metrics


Assertio Therapeutics, Inc. (ASRT)

Today's Latest Price: $0.66 USD

0.01 (1.43%)

Updated Sep 25 4:00pm

Add ASRT to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 233 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

ASRT Stock Summary

  • With a one year PEG ratio of 0.11, Assertio Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 3% of US stocks.
  • With a year-over-year growth in debt of -79.96%, Assertio Holdings Inc's debt growth rate surpasses only 2.55% of about US stocks.
  • Assertio Holdings Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 733.59%, greater than the shareholder yield of 98.94% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Assertio Holdings Inc are TGA, PLOW, TDW, BSM, and FET.
  • ASRT's SEC filings can be seen here. And to visit Assertio Holdings Inc's official web site, go to www.assertiotx.com.
ASRT Daily Price Range
ASRT 52-Week Price Range

ASRT Stock Price Chart Technical Analysis Charts


ASRT Price/Volume Stats

Current price $0.66 52-week high $1.71
Prev. close $0.65 52-week low $0.55
Day low $0.63 Volume 504,270
Day high $0.67 Avg. volume 1,355,861
50-day MA $0.82 Dividend yield N/A
200-day MA $0.93 Market Cap 70.82M

Assertio Therapeutics, Inc. (ASRT) Company Bio


Assertio Therapeutics, Inc. (formerly DepoMed) develops products for pain and other central nervous system conditions in the United States. The company was founded in 1995 and is focused in Newark, California.


ASRT Latest News Stream


Event/Time News Detail
Loading, please wait...

ASRT Latest Social Stream


Loading social stream, please wait...

View Full ASRT Social Stream

Latest ASRT News From Around the Web

Below are the latest news stories about Assertio Holdings Inc that investors may wish to consider to help them evaluate ASRT as an investment opportunity.

Field Roast's Chao Creamery Expands Dairy-Free Cheese Portfolio With Five New Varieties

Field Roast, the maker of the 1 selling plant-based cheese slice variety in U.S. retail, introduced 5 new dairy-free cheese flavors and forms.

Yahoo | September 15, 2020

IDENTOS access control technology is part of an innovative $5.9 million federal investment for a health access platform

At launch, the TRUSTSPHERE platform will help connect families, caregivers and clinicians to improve patient-centered care for children with Type 1 diabetes at BC Children's Hospital, and improve the process to donate clinical data to research TORONTO, Sept. 9, 2020 /CNW/ - As part of the Digital Technology Supercluster's $153 million investment to solve some of industry and society's biggest problems through Canadian-made technologies, the TRUSTSPHERE platform is being developed by a consortium led by Careteam Technologies which includes: IDENTOS, the University of British Columbia, SecureKey, Smile CDR, and MedStack to first be used by BC Children's Hospital in helping children with Type 1 diabetes.

Yahoo | September 9, 2020

Assertio to Present at Cantor Virtual Global Healthcare Conference on September 16, 2020

LAKE FOREST, Ill., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a commercial-stage pharmaceutical company, announced that the company will present at and participate in investor meetings at the Cantor Virtual Global Healthcare Conference. President, chief executive officer and director of Assertio, Todd Smith, will participate in the fireside chat with analyst Louise Chen on September 16, 2020 at 2:00 pm ET. The topics to be covered will be the status of the integration of Zyla Life Sciences, and the company’s business development strategy, financial results, current growth trends and milestones over the coming 12 months. The Cantor Virtual Global Healthcare Conference 2020 will take place September 15, 16 and 17, 2020. For th...

Yahoo | September 9, 2020

Q&A-Why is China suspending imports from some meat processors?

Top meat importer China has suspended imports from some foreign meat packing plants where workers became infected with coronavirus - but not others. China is the world's top meat importer, bringing in huge volumes in recent months because of a shortfall at home. Authorities in Beijing found heavy traces of the coronavirus in the meat and seafood sections of the Xinfadi market, a large wholesale food market in Beijing, after an outbreak there in June.

Yahoo | August 25, 2020

How Much Is Maple Leaf Foods Inc. (TSE:MFI) Paying Its CEO?

Michael McCain became the CEO of Maple Leaf Foods Inc. (TSE:MFI) in 1999, and we think it's a good time to look at the...

Yahoo | August 25, 2020

Read More 'ASRT' Stories Here

ASRT Price Returns

1-mo -18.15%
3-mo -23.89%
6-mo 1.54%
1-year -49.62%
3-year -88.30%
5-year -95.74%
YTD -47.20%
2019 -65.37%
2018 -55.16%
2017 -55.33%
2016 -0.61%
2015 12.54%

Continue Researching ASRT

Here are a few links from around the web to help you further your research on Assertio Therapeutics Inc's stock as an investment opportunity:

Assertio Therapeutics Inc (ASRT) Stock Price | Nasdaq
Assertio Therapeutics Inc (ASRT) Stock Quote, History and News - Yahoo Finance
Assertio Therapeutics Inc (ASRT) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7415 seconds.